Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.

Trials - 16 Feb 2022

Kautz-Freimuth Sibylle, Redaèlli Marcus, Isselhard Anna, Shukri Arim, Vodermaier Andrea, Rhiem Kerstin, Schmutzler Rita, Stock Stephanie

Abstract excerpt

BACKGROUND: Women with BRCA1/2 mutations have a higher risk of developing breast and ovarian cancer compared to women of the general population. Various preventive options are available to deal with the increased risk of developing cancer. These include intensified breast cancer screening and risk-reducing bilateral mastectomy and salpingo-oophorectomy. The choice of a preventive option can lead to increased...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Decision Support Techniques

Share to Germany

Share to Mastectomy

Share to Ovarian Neoplasms

Share to Randomized Controlled Trials as Topic

Source

Open in PubMed Open full text

Identifiers

PMID: 35172875
DOI: 10.1186/s13063-022-06081-7
PMCID: PMC8848811

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.PMID 35172875Read ↗

Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.Semantic proximity Read ↗

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.Semantic proximity Read ↗

Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Decision aids for female BRCA mutation carriers: a scoping review protocol.Semantic proximity Read ↗

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.Semantic proximity Read ↗

Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study.Semantic proximity Read ↗

Decision Coaching for Healthy Women With BRCA1/2 Pathogenic Variants—Findings of the Randomized Controlled EDCP-BRCA Trial.Semantic proximity Read ↗

Complex decision-making for BRCA1/2 carriers.Semantic proximity Read ↗

Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers.Semantic proximity Read ↗

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.Semantic proximity Read ↗

Decision aids for female BRCA mutation carriers: a scoping review.Semantic proximity Read ↗

A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.